Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Peter Mariani Insider Profile
11 Followers
Peter Mariani, CFO at Hansen Medical, holds 401.36K shares in Cytosorbents (Ticker: CTSO), holds 63.60K shares in AxoGen (Ticker: AXGN), holds 0.00 shares in Hansen Medical (Ticker: HNSN). Most recently, Peter Mariani Bought ― shares of Cytosorbents on Dec 16, 2024 for an estimated value of 19.20K.
Profitable Transactions
3 out of 5 Profitable Transactions
Average Return
+19.70%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Most Profitable Insider Trade
The most profitable trade made by Peter Mariani
Peter Mariani's Trading History
Hansen Medical
Feb 27, 2014
―
Informative Sell
128.73K
$0.00
AxoGen
Dec 13, 2023
EVP & CFO
Informative Sell
93.81K
$994.75K
Cytosorbents
Dec 16, 2024
CFO
Informative Buy
19.20K
$367.25K
List of latest transactions for each holding click on a transaction to see Peter Mariani's performance on stock
You May Also Like
Peter Mariani insider profile FAQ
What is the percentage of profitable transactions made by Peter Mariani?
The percentage of profitable transactions made by Peter Mariani is 60%.
What is the average return per transaction made by Peter Mariani?
The average return per transaction made by Peter Mariani is 19.70%.
What stocks does Peter Mariani hold?
Peter Mariani holds: HNSN, AXGN, CTSO stocks.
What was Peter Mariani’s latest transaction?
Peter Mariani latest transaction was an Informative Buy of $19.20K.
What was Peter Mariani's most profitable transaction?
Peter Mariani’s most profitable transaction was an Informative Buy of AXGN stock on October 14, 2016. The return on the trade was 122.40%.
What is Peter Mariani's role in Hansen Medical?
Peter Mariani's role in Hansen Medical is CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.